GENE ONLINE|News &
Opinion
Blog

Summits
Mycenax Teams Up with Global Partners to Expedite R&D and Market Launch of Next-Generation ADCs
2026-09-14
A Foundation Tempered by Time: How San Antonio is Rising as a Strategic Hub for the US Life Sci
2026-09-07
Austin’s Biotech Cluster: Lighting the Beacon of Innovation in the Lone Star State
2026-09-01
A New Wave of Bridging Borders: How US-Asia Biotech Leverages Hybrid Models to Rewrite the Rules of the Game
2026-07-03
Global Biotech M&A Shows Signs of Recovery, Clinical Data and Efficacy Emerge as Key Deal-Breakers
2026-07-03
Biopharma Leaders Confront Operational Realities and Data Hurdles at BIO 2026 AI Summit
2026-07-02
Taiwan Biotech Delegation Advances: Forging Global Partnerships at BIO 2026
2026-06-30
EirGenix Showcases Dual-Track Biosimilars and CDMO Strategy in U.S. Market Push at BIO 2026
2026-06-29
BIO CEO John F. Crowley on Unifying Regulation, Artificial Intelligence, and National Security into a Singular Competitiveness Agenda in Bio Sector
2026-06-26
Arizona and Taiwan Sign MOU to Foster Bilateral Biotech Exchange and Collaboration
2026-06-26
BIO International Convention 2026 Soar High, Fifty Years of Innovation Unfolds
2026-06-24
2026 Taiwan Biotech Forum Shines in San Diego, Spotlighting Precision Medicine Innovations
2026-06-22
Six Taipei Biotechs Head to BIO 2026 in San Diego, With Precision Medicine, Drug Delivery, and Bioprocess Innovation in Focus
2026-06-18
The Computer Was Built for Humans. At GTC Taipei, Jensen Huang Just Built One for AI
2026-06-01
Can Global Healthcare Systems Stay Resilient Without Reinventing Pharmaceutical Manufacturing?
2026-05-20
1 2
LATEST
Wendy Short Bartie Repositions Bristol Myers Squibb Corporate Affairs to Integrate Patient Advocacy and Healthcare Access
2026-09-14
Wendy Short Bartie Restructures Bristol Myers Squibb Corporate Affairs to Link Reputation with Business Performance
2026-09-14
Wendy Short Bartie Integrates Patient Advocacy and Public Trust into Bristol Myers Squibb Business Strategy
2026-09-14
Chinese Bispecific Antibody Tops Keytruda in First Head-to-Head OS Win; SMA Muscle-Strengthening Therapy Approved, B7-H3 ADC Shows Promise
2026-09-14
FDA Approves Bayer’s Sevabertinib as First-Line Treatment for Adults Living with HER2-Mutant Lung Cancer
2026-09-14
Takeda R&D President Andy Plump and GV Managing Partner Krishna Yeshwant Announce Retirements
2026-09-12
Shine Spect USA Updates Clinical and Safety Guidelines for Xenon Xe-133 Gas
2026-09-11
Scroll to Top